Abstract Background Inflammatory myofibroblastic tumors (IMTs) are rare intermediate-
grade neoplasms that have a high recurrence rate after excision and exhibit low metastatic …

Simple Summary Among sarcomas, which are rare cancers, inflammatory myofibroblastic
tumors are extremely rare. Unlike other subtypes, this is a largely oncogene-driven …

Activating neurotrophic tyrosine receptor kinase (NTRK) fusions, typically detected using
nucleic-acid based assays, are highly targetable and define certain tumors. Here, we …

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor of intermediate
malignant potential that predominantly affects children, adolescents and young adults. IMT …

Anaplastic large cell lymphoma (ALCL) was first described in 1985 as a large-cell neoplasm
with anaplastic morphology immunostained by the Ki-1 antibody, which recognizes CD30. In …

Background Genomic fusions of the anaplastic lymphoma kinase gene (ALK) are a well‐
established therapy target in non‐small cell lung cancer (NSCLC). From a survey of 114,200 …

Inflammatory myofibroblastic tumors of the uterus are rare, and although most have a
favorable prognosis, a small subset exhibit extrauterine disease, recur, or cause death. In …

Juvenile myelomonocytic leukemia (JMML), a rare and aggressive myelodysplastic/
myeloproliferative neoplasm that occurs in infants and during early childhood, is …

Rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small cell lung
cancer (NSCLC) represent a novel molecular target in a small subset of tumors. Although …

Nodular fasciitis is a self-limited myofibroblastic lesion that can be misdiagnosed as a
sarcoma as a result of its rapid growth, cellularity, and sometimes prominent mitotic activity …